These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20564974)

  • 1. [Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].
    Wultańska D; Obuch-Woszczatyński P; Banaszkiewicz A; Radzikowski A; Pituch H; Młynarczyk G
    Med Dosw Mikrobiol; 2010; 62(1):77-84. PubMed ID: 20564974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
    Chen YB; Gu SL; Shen P; Lv T; Fang YH; Tang LL; Li LJ
    J Med Microbiol; 2018 Jan; 67(1):52-59. PubMed ID: 29160203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
    Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
    Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
    Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Clostridium difficile isolates from human fecal samples and retail meat from Pennsylvania.
    Varshney JB; Very KJ; Williams JL; Hegarty JP; Stewart DB; Lumadue J; Venkitanarayanan K; Jayarao BM
    Foodborne Pathog Dis; 2014 Oct; 11(10):822-9. PubMed ID: 25269079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.
    Kuwata Y; Tanimoto S; Sawabe E; Shima M; Takahashi Y; Ushizawa H; Fujie T; Koike R; Tojo N; Kubota T; Saito R
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):763-72. PubMed ID: 25471195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance of Clostridium difficile isolates.
    Dworczyński A; Sokół B; Meisel-Mikołajczyk F
    Cytobios; 1991; 65(262-263):149-53. PubMed ID: 1828756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
    Alcides AP; Brazier JS; Pinto LJ; Balassiano IT; Boente RF; de Paula GR; Ferreira EO; Avelar KE; Miranda KR; Ferreira MC; Domingues RM
    Antonie Van Leeuwenhoek; 2007 Jul; 92(1):53-9. PubMed ID: 17252315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile carriage in healthy pregnant women in China.
    Ye GY; Li N; Chen YB; Lv T; Shen P; Gu SL; Fang YH; Li LJ
    Anaerobe; 2016 Feb; 37():54-7. PubMed ID: 26633756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients.
    Baghani A; Ghourchian S; Aliramezani A; Yaseri M; Mesdaghinia A; Douraghi M
    J Appl Microbiol; 2018 Nov; 125(5):1518-1525. PubMed ID: 29957893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    Leroi MJ; Siarakas S; Gottlieb T
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):72-4. PubMed ID: 11913510
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.